Dietary pulverized konjac glucomannan suppresses scratching behavior and skin inflammatory immune responses in NC/Nga mice

Int Arch Allergy Immunol. 2007;144(2):95-104. doi: 10.1159/000103220. Epub 2007 May 24.

Abstract

Background: Feeding with pulverized konjac glucomannan (PKGM) suppresses the development of eczema and hyper-IgE production in NC/Nga mice, a model of atopic dermatitis. This study aimed to examine the effects of PKGM on scratching behavior and skin inflammatory immune responses in NC/Nga mice.

Methods: Four-week-old NC/Nga mice were maintained for 8 or 9 weeks on diet containing PKGM. Scratching behavior and clinical symptoms were evaluated every 2 weeks. Effects of PKGM on cutaneous inflammation were evaluated by histopathological analysis. Local expression levels of substance P and proinflammatory cytokines were measured by ELISA.

Results: An increase in scratching behavior was evident from 6 weeks of age in control mice, but this symptom was dose-dependently inhibited in PKGM-fed mice. Continuous PKGM feeding then significantly inhibited eczematous skin lesions including hyperkeratosis, dermal mastocytosis and eosinophilia. Concomitantly, cutaneous overproductions of substance P, IL-10, IL-4, and TNF-alpha were all suppressed in PKGM-fed mice.

Conclusions: PKGM feeding markedly suppressed development of scratching behavior, substance P expression with mastocytosis, and skin inflammatory immune responses in NC/Nga mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dermatitis, Atopic / drug therapy*
  • Dietary Carbohydrates / administration & dosage
  • Dietary Carbohydrates / therapeutic use*
  • Disease Models, Animal
  • Ear / pathology
  • Eosinophilia / immunology
  • Immunoglobulin E / blood
  • Immunoglobulin G / blood
  • Interferon-alpha / metabolism
  • Interleukin-10 / metabolism
  • Interleukin-4 / metabolism
  • Keratosis / drug therapy
  • Keratosis / immunology
  • Keratosis / pathology
  • Male
  • Mannans / administration & dosage
  • Mannans / therapeutic use*
  • Mastocytosis, Cutaneous / drug therapy*
  • Mastocytosis, Cutaneous / immunology
  • Mice
  • Mice, Inbred Strains
  • Pruritus / drug therapy*
  • Pruritus / immunology
  • Pruritus / pathology
  • Skin / immunology
  • Skin / pathology
  • Substance P / metabolism

Substances

  • Dietary Carbohydrates
  • Immunoglobulin G
  • Interferon-alpha
  • Mannans
  • Interleukin-10
  • Interleukin-4
  • Substance P
  • (1-6)-alpha-glucomannan
  • Immunoglobulin E